Although it has been demonstrated repeatedly that, ATP is a fast excitatory
transmitter in the central nervous system (CNS), there are only limited da
ta to indicate a corelease of ATP with other transmitters such as gamma -am
inobutyric acid or noradrenaline. Somewhat surprisingly, there is no eviden
ce hitherto for glutamate-ATP cotransmission in spite of the widespread dis
tribution of glutamatergic neurons in the brain and spinal cord. However, A
TPergic and glutamatergic neurons may interact both at the pre- and postsyn
aptic level. Presynaptic P2X receptors facilitate glutamate release both fr
om the terminals of mesencephalic proprioceptive trigeminal neurons project
ing to the motor trigeminal nucleus in the brainstem and from primary affer
ent fibers onto dorsal horn neurons of the spinal cord. The inhibitory effe
ct of ATP via presynaptic P2Y receptors has been demonstrated convincingly
at noradrenergic but not glutamatergic nerve terminals. However, in additio
n to the direct effects of ATP adenosine formed by the enzymatic degradatio
n of ATP can inhibit the release of glutamate from the Schaffer collateral-
commissural pathway onto CA1 pyramidal cells of the hippocampus. Similarly
ATP degraded to adenosine may inhibit the N-methyl-D-aspartate (NMDA)-induc
ed current in the striatopallidal subpopulation of medium spiny neurons via
A(2A) receptor activation. Finally, ATP may potentiate the NMDA receptor-m
ediated depolarization or the underlying inward current at layer V pyramida
l neurons of the prefrontal cortex, and P2Y receptors have been suggested t
o mediate this interaction. Thus, although as a transmitter ATP alters the
membrane potential of a limited subset of CNS neurons, it may have widespre
ad and pronounced effects by modulating glutamatergic mechanisms. Drug Dev.
Res. 52:76-82, 2001. (C) 2001 Wiley-Liss, Inc.